MedPath

Closure After Total Shoulder Arthroplasty: Prineo vs Dermabond

Not Applicable
Terminated
Conditions
Shoulder Arthropathy Associated With Other Conditions
Shoulder Arthritis
Interventions
Device: 2-Octyl Cyanoacrylate and Mesh
Device: 2-Octyl Cyanoacrylate
Registration Number
NCT03899753
Lead Sponsor
Montefiore Medical Center
Brief Summary

The objective is to compare two types of wound closure after total shoulder arthroplasty to determine which closure is faster, and subsequently if there are different outcomes between the two types of closures.

The objective of this study is to compare two types of wound closure after total shoulder arthroplasty procedures. A single fellowship trained shoulder surgeon will perform all procedures. It is hypothesized that participants who undergo an 2-Octyl Cyanoacrylate (OCA) mesh closure will have a faster closure time, lower cost, non-inferior complication rate, and non-inferior satisfaction scores with respect postoperative follow up and scar appearance.

Participants in the OCA mesh cohort will be compared to participants who have a closure with a running monocryl suture and dermabond. This investigation seeks to determine if OCA closure mesh closure is non-inferior to monocryl suture and dermabond in terms of operative time, cost, complications, and aesthetic appearance.

If the hypothesis is confirmed, this study will suggest that a OCA mesh closure may be used for total shoulder arthroplasty surgeries as an alternative to current conventional closures and may provide a cost benefit.

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
1
Inclusion Criteria
  • Total shoulder arthroplasty
  • Reverse total shoulder arthroplasty
  • Age 18-100
  • Single Surgeon
Exclusion Criteria
  • Previous shoulder surgery
  • Known wound healing complications
  • DM, chronic steroid use, vascular insufficiency, morbid obesity (BMI>40), ESRD, family hx of pathologic scars
  • Patients on blood thinners (ASA 81mg ok)
  • Connective tissue disease
  • Allergy to skin adhesive
  • Mentally unable to complete questionnaires
  • Previous wound over planned incision

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
2-Octyl Cyanoacrylate and mesh2-Octyl Cyanoacrylate and MeshThe wound will be closed with 2-Octyl Cyanoacrylate and a mesh
2-Octyl Cyanoacrylate2-Octyl CyanoacrylateThe wound will be closed with just 2-Octyl Cyanoacrylate
Primary Outcome Measures
NameTimeMethod
Time for Incision ClosureDuring surgery (approximately 40 minutes)

A stopwatch will be used to measure the time it takes for the incision to be closed. When the surgical implants are in place and irrigation is complete, the surgeon will announce that he will start the closure and a nurse will start the stopwatch to measure how long it takes for the surgeon to close the incision.

Secondary Outcome Measures
NameTimeMethod
Superficial InfectionAt each follow up visit up to 3 months after surgery

Number of wounds with superficial skin infections will be reported

Cost of ClosureImmediately post surgery

Cost of closure will be assessed by the cost of the time in the operating room and the cost of materials used to close the incision

Number of Wounds That Require Post Operative InterventionAt each follow up visit up to 3 months after surgery

Will report the number of wounds that require post operative intervention

Wound AppearanceAt each follow up visit up to 3 months after surgery

The surgeon and participant will fill out the Patient and Observer Scar Assessment Scale (POSAS). This is a survey used to assess the participant and the surgeons opinion of the appearance of the wound. The Patient and Observer Scar Assessment Scale (POSAS) is a questionnaire that was developed to assess scar quality. It consists of two separate six-item scales (Observer Scale and Patient Scale), both of which are scored on a 10-point rating scale. Each questionnaire consists of 7 questions, each graded 1 through 10. The minimum score is 7 (most like normal skin) and the maximum score is 70 (very different from normal skin). The observer is the surgeon. The observer and patient scores can then be added together to determine the collective score.

DehiscenceAt each follow up visit up to 3 months after surgery

The wound will be assessed for dehiscence (incision opening) which will be recorded as a "yes or no". A dehiscence is defined as exposure of the underlying subcutaneous fat secondary to failure of the epidermal healing and may be accompanied by persistent wound drainage. It will be assessed by the length of the opening in centimeters and then normalized against the length of the entire incision. Furthermore, the number of wounds that open will be reported

Wound DrainageAt first post operative visit

Dressing for each participant after surgery will be regulated and changed by the surgeon at the first post op visit. Drainage will be measured by outlining the drainage on gauze onto graph paper and measuring the area as previously validated in prior studies

Deep Wound InfectionAt each follow up visit up to 3 months after surgery

Number of deep wound infections found will be reported

Trial Locations

Locations (1)

Jack D. Weiler Hospital-Division of Montefiore Medical Center

🇺🇸

Bronx, New York, United States

© Copyright 2025. All Rights Reserved by MedPath